Bladder
Cancer Diagnostics Market: Introduction
·
Bladder cancer is a urologic malignancy
occurring in the tissues of the urinary bladder. It is characterized by
uncontrolled, rapid growth of cells arising from the epithelial lining, which
can proliferate to the muscular wall of urinary bladder.
·
The bladder or urinary bladder is a hollow
organ located in the pelvis (lower abdomen), which stores the urine drained
from kidney
·
It is connected to the kidney by ureter, a
tube like structure. Bladder cancer is ranked as the ninth most frequently
diagnosed cancer
·
The exact cause of bladder cancer is not
known. However, some of the risk factors such as excessive smoking, tobacco
consumption, and continuous exposure to radiation, chronic bladder infection,
and previous cancer treatments are considered to cause bladder cancer.
·
Bladder cancer can affect any age group;
however, it is more prevalent in adults aged over 50
Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=78700
Key
Drivers of Global Bladder Cancer Diagnostics Market
·
The global bladder cancer diagnostics
market is driven by increase in incidence of bladder cancer, which has led to
drug innovation
·
Bladder cancer is more common in adults
aged over 50. Hence, increase in the geriatric population contributes to market
growth.
·
Government initiatives, rise in awareness
about bladder cancer & available treatments, and progressive health care
services due to surge in health care expenditure are projected to propel the
global market
·
However, cancer being an asymptomatic
disease at the initial stage needs accurate diagnosis at early stage.
Inaccurate and unaffordable diagnosis is likely to hamper the growth of the
global market.
Request a Sample of Bladder Cancer Diagnostics Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=78700
Biopsy
Segment to Dominate Global Market
·
In terms of test type, the global bladder
cancer diagnostics market can be divided into urine lab tests, cystoscopy,
biopsy, and imaging test. The urine lab tests segment can be split into
urinalysis, urine cytology, urine culture, and urine tumor marker test. The
imaging tests segment can be segregated into intravenous pyelogram (IVP),
computed tomography (CT) scan, magnetic resonance imaging (MRI) scan, and
ultrasound.
·
The imaging test segment accounted for the
largest market share in 2019 owing to high utilization of imaging tests for the
diagnosis of bladder cancer. Imaging test allows a doctor to examine the structures
of the urinary tract.
Request for Analysis of COVID19 Impact on Bladder Cancer
Diagnostics Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=78700
Transitional
Cell Bladder Cancer to be Highly Attractive Segment
·
In terms of cancer type, the global bladder
cancer diagnostics market can be classified into transitional cell bladder
cancer, squamous cell bladder cancer, and other cancer types
·
The transitional cell bladder cancer
segment is expected to account for major share of the global bladder cancer
diagnostics market by 2030 owing to high incidence of transitional cell bladder
cancer
Hospitals
to be Highly Lucrative Segment
·
Based on end-user, the global bladder
cancer diagnostics market can be categorized into hospitals, clinics, cancer
centers, and others
·
The hospitals segment is likely to account
for major share of the global bladder cancer diagnostics market by 2030 due to
increase in hospitalization for bladder cancer
Pre-Book Bladder Cancer Diagnostics Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=78700<ype=S
North
America to Offer Significant Opportunities in Bladder Cancer Diagnostics Market
·
In terms of region, the global bladder
cancer diagnostics market can be segmented into North America, Europe, Asia
Pacific, Latin America, and Middle East & Africa
·
North America accounted for major share of
the global market in 2019 owing to increase in incidence of bladder cancer,
innovative health care solutions, advanced health care infrastructure, and rise
in concern about bladder problems. Europe accounted for the second largest
share of the global market in 2019.
·
The bladder cancer diagnostics market in
Asia Pacific is projected to expand at a high CAGR during the forecast period.
This is attributed to rise in awareness about bladder disease and innovative
diagnostic & treatment options. Major players find countries in Asia to be
lucrative markets for bladder cancer diagnostics and are making significant
investments.
Key
Players Operating in Global Bladder Cancer Diagnostics Market
The global
bladder cancer diagnostics market is semi-consolidated, with the presence of
international and local players.
More Trending Reports by Transparency
Market Research:
https://www.prnewswire.co.uk/news-releases/carbon-therapy-segment-in-particle-therapy-market-to-grow-at-exponential-growth-rate-from-2018-to-2026-tmr-848789727.html
https://www.prnewswire.com/news-releases/strides-in-positive-airway-pressure-devices-market-help-reduce-worldwide-prevalence-of-obstructive-sleep-apnea-valuation-to-rise-at-cagr-of-7-8-from-2019-to-2027-tmr-301136571.html
About Us
Transparency Market
Research is a global market intelligence company providing global business
information reports and services. Our exclusive blend of quantitative forecasting
and trends analysis provides forward-looking insight for several decision
makers. Our experienced team of analysts, researchers, and consultants uses
proprietary data sources and various tools and techniques to gather and analyze
information.
Our data repository is
continuously updated and revised by a team of research experts so that it
always reflects latest trends and information. With a broad research and
analysis capability, Transparency Market Research employs rigorous primary and
secondary research techniques in developing distinctive data sets and research
material for business reports.
Contact
Transparency Market
Research,
90 State Street, Suite
700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free:
866-552-3453
Website: https://www.transparencymarketresearch.com/
